Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Matteo Lambertini, Christine Campbell, José Bines, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 111, Iss. 1, pp. 86-94
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

ESHRE guideline: female fertility preservation†
Richard A. Anderson, Frédéric Amant, D.D.M. Braat, et al.
Human Reproduction Open (2020) Vol. 2020, Iss. 4
Open Access | Times Cited: 494
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†
Matteo Lambertini, Fedro A. Peccatori, Isabelle Demeestere, et al.
Annals of Oncology (2020) Vol. 31, Iss. 12, pp. 1664-1678
Open Access | Times Cited: 344
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
Olivia Pagani, Prudence A. Francis, Gini F. Fleming, et al.
Journal of Clinical Oncology (2019) Vol. 38, Iss. 12, pp. 1293-1303
Open Access | Times Cited: 124
Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application
Matteo Lambertini, Florence Horicks, Lucia Del Mastro, et al.
Cancer Treatment Reviews (2018) Vol. 72, pp. 65-77
Closed Access | Times Cited: 101
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial
Soo Yeon Baek, Woo Chul Noh, Sei‐Hyun Ahn, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 31, pp. 4864-4871
Closed Access | Times Cited: 28
Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors
Hildur Helgadóttir, Alexios Matikas, Josefin Fernebro, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114010-114010
Open Access | Times Cited: 9
Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
Alexandra Thomas, Anthony Rhoads, Elizabeth Pinkerton, et al.
JNCI Cancer Spectrum (2019) Vol. 3, Iss. 3
Open Access | Times Cited: 70
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials
Matteo Lambertini, Samuel Martel, Christine Campbell, et al.
Cancer (2018) Vol. 125, Iss. 2, pp. 307-316
Open Access | Times Cited: 63
Oncofertility and Reproductive Counseling in Patients with Breast Cancer: A Retrospective Study
Simona Zaami, Rossella Melcarne, Renato Patrone, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1311-1311
Open Access | Times Cited: 36
The Impact of Systemic Oncological Treatments on the Fertility of Adolescents and Young Adults—A Systematic Review
Justine Himpe, Sander Lammerant, L. Van Den Bergh, et al.
Life (2023) Vol. 13, Iss. 5, pp. 1209-1209
Open Access | Times Cited: 20
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer
Matteo Lambertini, Marcello Ceppi, Richard A. Anderson, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 1, pp. 33-41.e16
Open Access | Times Cited: 16
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 51
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Rafael Caparica, Marco Bruzzone, Francesca Poggio, et al.
Breast Cancer Research and Treatment (2018) Vol. 174, Iss. 1, pp. 27-37
Closed Access | Times Cited: 49
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer
Nikita Shah, Dana M. Scott, Pridvi Kandagatla, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 5, pp. 1214-1224
Open Access | Times Cited: 44
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients
Ana Santaballa, Catalina Márquez-Vega, Álvaro Rodríguez-Lescure, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 2, pp. 227-243
Open Access | Times Cited: 36
Approaches to Fertility Preservation for Young Women With Breast Cancer
Maria Grazia Razeti, Davide Soldato, Luca Arecco, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 3, pp. 241-248
Closed Access | Times Cited: 15
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Wanda Cui, Rodney P. Rocconi, Ramya Thota, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 10, pp. e415-e423
Open Access | Times Cited: 14
Breast cancer: an update on treatment-related infertility
Erica Silvestris, Miriam Dellino, Paola Cafforio, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 3, pp. 647-657
Closed Access | Times Cited: 34
Gender-specific aspects related to type of fertility preservation strategies and access to fertility care
Marta Perachino, Claudia Massarotti, Maria Grazia Razeti, et al.
ESMO Open (2020) Vol. 5, pp. e000771-e000771
Open Access | Times Cited: 33
Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
Mark van Barele, Bernadette A. M. Heemskerk‐Gerritsen, Yvonne V. Louwers, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2506-2506
Open Access | Times Cited: 32
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients
Matteo Lambertini, Luca Boni, Andrea Michelotti, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 3, pp. 400-408
Open Access | Times Cited: 29
Fertility Preservation in Young Women With Breast Cancer: A Review
Yeon Hee Hong, Changhee Park, Haerin Paik, et al.
Journal of Breast Cancer (2023) Vol. 26, Iss. 3, pp. 221-221
Open Access | Times Cited: 11
Impact of Breast Cancer Systemic Therapies on Fertility
Jasmin Hundal, Halle C. F. Moore
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Open Access
Fertility preservation methods in the context of breast cancer treatment: real-life experience and prospects
Aliya Zagidullina, L. A. Dzhambulatova, M. A. Shatueva, et al.
Obstetrics Gynecology and Reproduction (2025)
Open Access
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor–Positive Breast Cancer
Matteo Lambertini, Eva Blondeaux, Francesco Perrone, et al.
Journal of Clinical Oncology (2019) Vol. 38, Iss. 12, pp. 1258-1267
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top